Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons - Wikidata - wikimedia - TriplyDB

Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons

Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons

http://www.wikidata.org/entity/Q35189962

about

Urinary Markers of Tubular Injury in HIV-Infected Patients Association of low level viremia with inflammation and mortality in HIV-infected adults Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine.Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.Inflammatory cytokines and mortality in a cohort of HIV-infected adults with alcohol problems.Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals Serum albumin and kidney function decline in HIV-infected women A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans.Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial.Reduced kidney function and preclinical atherosclerosis in HIV-infected individuals: the study of fat redistribution and metabolic change in HIV infection (FRAM)The association of adiposity with kidney function decline among HIV-infected adults: findings from the Fat Redistribution and Metabolic Changes in HIV Infection (FRAM) study Cystatin C-based renal function changes after antiretroviral initiation: a substudy of a randomized trial.HIV viremia and T-cell activation differentially affect the performance of glomerular filtration rate equations based on creatinine and cystatin C.Relationships between renal parameters and serum and urine markers of inflammation in those with and without HIV infection Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.Renal disease in HIV-infected individuals APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease.Albuminuria Is Associated with Traditional Cardiovascular Risk Factors and Viral Load in HIV-Infected Patients in Rural South Africa.Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors.Elevation of Non-Classical (CD14+/lowCD16++) Monocytes Is Associated with Increased Albuminuria and Urine TGF-β1 in HIV-Infected Individuals on Stable Antiretroviral Therapy.Markers of renal disease and function are associated with systemic inflammation in HIV infection.Prevalence of proteinuria and elevated serum cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) study Cystatin C-Based Evaluation of Kidney Function of HIV-Infected Children in Benin City, Southern Nigeria.Urinary markers of kidney injury and kidney function decline in HIV-infected women The Incidence and Clinical Characteristics of Acute Serum Creatinine Elevation more than 1.5 mg/dL among the Patients Treated with Tenofovir/Emtricitabine-containing HAART Regimens Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients.Accelerated Aging in HIV Patients.Association of tenofovir exposure with kidney disease risk in HIV infection.Update on cystatin C: incorporation into clinical practice.The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy: Meta-analysis.Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection Does HIV infection promote early kidney injury in women?Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals.Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS).Impaired Urine Dilution Capability in HIV Stable Patients.Renal issues in HIV infection.

P2860

Q26738912-7604D75B-B0BF-4E52-8405-06B1AE31B2BA Q28743237-B19DF32D-2942-4044-9CC5-2CD681A4E778 Q30842348-3D15301D-B926-47D6-9C57-6B84DAED584E Q33625213-CDB5DF6D-63C5-4F82-9FDE-BE692621A01D Q33926735-FC8B8F29-2F3A-47A9-879A-8FFD054CF838 Q34048920-46A6C9AF-A602-4695-A68C-30FF837DCB79 Q34254770-E19531F4-AAEC-4209-BA67-395EF1EA83DB Q34301401-2E8C9E6D-F267-4E8F-A5D4-36CC75618A21 Q34584634-11B02DE3-D595-4470-B8D1-35F68DE4A162 Q34736194-74CFCEDD-18FD-4211-B610-15753FF51920 Q34736818-15E9028A-08FE-4BC7-82FE-EC0C6465C447 Q35000346-B61B3C4E-7F0E-44C7-A2E6-55DB44859F09 Q35060772-3D1DA98C-1D63-4E84-B385-0740755EACB7 Q35071954-9F97CD54-3179-4BB1-82B3-8BC6713F5E67 Q35077530-540B81FD-F5CC-4BBB-AA46-CD92C49BFE48 Q35230397-80815BFE-E190-4E2A-813B-AC6FDAA98FB6 Q35652795-8712E5D8-2DB9-4C25-BF2D-0A8A457D2473 Q35698442-CD8F5D55-B6D1-4D6C-8FE9-A2F58532F3F5 Q35715828-407D3074-DF5B-4653-9D0D-FA88E97EAE13 Q35756256-126D500E-6550-4BB7-A0C7-77C469B26048 Q35883947-895DF7D9-8B3B-450D-ADB3-776917BDF498 Q35994939-389F697B-62B2-4C4A-BAA4-F178FDC52F44 Q36206108-4CC088B7-8522-4F26-84EF-1169506FDD99 Q36388998-42784D88-0318-469A-92FC-75CBBDE79DBC Q36425231-9BEB8DD4-C21E-4234-9EA9-6BD340DADF9A Q36431302-33DE1BF6-8F92-4C65-9FD2-45AA71BFD277 Q36472367-EC8DEDD1-987A-4928-BEAD-99205A300571 Q36492436-588931A7-1805-4EFC-82FE-65A4D8C1D1AF Q36852879-92BED065-FF93-491A-9A5E-0AA20AAD6E2D Q36919221-1CF43931-EC1C-45B5-B1B2-35ED7DC8F3E7 Q37077982-284AC6D2-7ACD-4CA4-AE65-8DEFB3976FCD Q37126287-FF7C121F-45DB-4EA2-9BAA-BBA90E7355BD Q37354871-E716CC37-2918-484B-A49B-489AAFADF6CC Q37574064-0062EB01-0BC8-43B5-AC95-7ED830365BDE Q37600614-18FA1999-1D4D-4374-B72C-144601F0AE2D Q37600838-6C208CD4-36C7-4D8E-A88B-CD0FCF1B669C Q37626254-0AE9C4C6-C38D-4DF4-9A18-6E510067F022 Q37684606-5FBD3F48-5ABB-4D55-BF6D-35A376499145 Q37706095-A305B11C-C6DD-4BE5-A8C7-94B19D74F11A Q37885232-04128957-0BB0-4A7D-AC41-7410C89317DA

P2860

Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons

http://www.wikidata.org/entity/Q35189962

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons

@ast

Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons

@en

type

label

Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons

@ast

Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons

@en

prefLabel

Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons

@ast

Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons

@en

P1433

Q35189962-2F11B626-6E37-4955-9CBC-247E1AD843EA

P1476

Q35189962-075F46B5-9CBE-4570-B629-8529D0479F78

P2093

Q35189962-1C1C96BA-D75F-4712-94A3-BF4BD52704A1

Q35189962-456841DC-D2EB-40B0-A38D-2799D482C879

Q35189962-5DDBE87B-F34E-4E2F-BED7-5EC8245E0467

Q35189962-8032028E-0D1A-4D6D-B421-61239333D130

Q35189962-88489742-75D2-43EB-B8BE-9589BCACFCF4

Q35189962-897C6AF9-C102-406D-9337-A27F2602BC1E

Q35189962-B7E61E91-A622-4F03-B35F-FBD09AAAD6F1

Q35189962-D3F7BA75-A886-479D-9DC8-9A5EB2B890F4

P2860

Q35189962-0288E873-FACB-4FE8-920B-9A0899319E51

Q35189962-090F535D-0E73-4534-B387-58B0507DD288

Q35189962-11AC91BC-6564-40D0-9EA3-B32A95759CC3

Q35189962-15A4EC75-28DD-4CC1-8E82-1551D568839F

Q35189962-2801A6A8-B1C8-4744-B33D-7BB621036011

Q35189962-2D83873C-B283-41AD-AF74-1FB69D432B50

Q35189962-2EC45712-CD36-47FF-A5A1-C105B143A2BF

Q35189962-3A34B9FA-96D8-4C28-9C41-630D4307D0FE

Q35189962-55D78517-4082-42F9-8903-F0A7EECA1B52

Q35189962-61391E65-0B4E-46AD-B5EF-3F63B9780BCB

P304

Q35189962-57D0812C-CF11-4C87-8B55-D161E9EE565A

P31

Q35189962-F1D77183-FDB0-4B56-A8A2-1C9BC6A276FD

P356

Q35189962-91BFA2CE-CF38-4AE9-A350-38C8A6F588A5

P433

Q35189962-D5635D8E-8C99-42A2-AE78-89CC25553E11

P478

Q35189962-6B793D9E-5C3C-4D31-A91E-4290A7B87FCD

P50

Q35189962-54814E16-8B6A-41C0-B8FC-FC71C0032EDF

P577

Q35189962-F1475FA6-8F70-4766-B5BA-193CB42AC96E

P5875

Q35189962-2EB460C1-E011-4E6C-AEC9-8512C0C7314F

P698

Q35189962-C69862DD-2AA8-443B-A65B-5BD27423220E

P932

Q35189962-5EFF4044-5F83-4BBB-89C0-9F5657088735

P356

J.AJKD.2010.05.019

P1433

American Journal of Kidney Diseases

P1476

Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons

@en

P2093

Andy Choi

http://www.w3.org/2001/XMLSchema#string

Carl Grunfeld

http://www.w3.org/2001/XMLSchema#string

Cynthia L Gibert

http://www.w3.org/2001/XMLSchema#string

Lynda A Szczech

http://www.w3.org/2001/XMLSchema#string

Michael S Saag

http://www.w3.org/2001/XMLSchema#string

Peter Bacchetti

http://www.w3.org/2001/XMLSchema#string

Phyllis C Tien

http://www.w3.org/2001/XMLSchema#string

Rebecca Scherzer

http://www.w3.org/2001/XMLSchema#string

P2860

Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD

Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis

Cystatin C and the risk of death and cardiovascular events among elderly persons

Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy

P304

872-882

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.AJKD.2010.05.019

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

Michael G Shlipak

P577

2010-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45650215

http://www.w3.org/2001/XMLSchema#string

P698

20709438

http://www.w3.org/2001/XMLSchema#string

P932

3164880

http://www.w3.org/2001/XMLSchema#string